The inhibitory effects of IL-12 on tumour vasculature were also associated with increased levels of the IFN-γ-inducible chemokine ligands CXCL9 and CXCL10 (IP-10) and decreased production of vascular endothelial growth factor (VEGF) [38]. The gene discussed is VEGFA; the disease is neoplasm.